OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High Prevalence of Skin Test Positivity in Severe or Difficult-to-Treat Asthma
Tmirah Haselkorn, Larry Borish, Dave P. Miller, et al.
Journal of Asthma (2006) Vol. 43, Iss. 10, pp. 745-752
Closed Access | Times Cited: 47
Tmirah Haselkorn, Larry Borish, Dave P. Miller, et al.
Journal of Asthma (2006) Vol. 43, Iss. 10, pp. 745-752
Closed Access | Times Cited: 47
Showing 1-25 of 47 citing articles:
The potential of biologics for the treatment of asthma
Girolamo Pelaia, Alessandro Vatrella, Rosario Maselli
Nature Reviews Drug Discovery (2012) Vol. 11, Iss. 12, pp. 958-972
Closed Access | Times Cited: 220
Girolamo Pelaia, Alessandro Vatrella, Rosario Maselli
Nature Reviews Drug Discovery (2012) Vol. 11, Iss. 12, pp. 958-972
Closed Access | Times Cited: 220
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study
Bradley E. Chipps, Robert S. Zeiger, Larry Borish, et al.
Journal of Allergy and Clinical Immunology (2012) Vol. 130, Iss. 2, pp. 332-342.e10
Open Access | Times Cited: 191
Bradley E. Chipps, Robert S. Zeiger, Larry Borish, et al.
Journal of Allergy and Clinical Immunology (2012) Vol. 130, Iss. 2, pp. 332-342.e10
Open Access | Times Cited: 191
Asthma: a syndrome composed of heterogeneous diseases
Larry Borish, Jeffrey A. Culp
Annals of Allergy Asthma & Immunology (2008) Vol. 101, Iss. 1, pp. 1-9
Closed Access | Times Cited: 127
Larry Borish, Jeffrey A. Culp
Annals of Allergy Asthma & Immunology (2008) Vol. 101, Iss. 1, pp. 1-9
Closed Access | Times Cited: 127
Clinical and immunological determinants of severe/refractory asthma (SRA): association with Staphylococcal superantigen-specific IgE antibodies
Marek L. Kowalski, M Cieślak, Claudina Pérez-Novo, et al.
Allergy (2010) Vol. 66, Iss. 1, pp. 32-38
Closed Access | Times Cited: 100
Marek L. Kowalski, M Cieślak, Claudina Pérez-Novo, et al.
Allergy (2010) Vol. 66, Iss. 1, pp. 32-38
Closed Access | Times Cited: 100
Infection-Related Asthma
Jared I. Darveaux, Robert F. Lemanske
The Journal of Allergy and Clinical Immunology In Practice (2014) Vol. 2, Iss. 6, pp. 658-663
Open Access | Times Cited: 80
Jared I. Darveaux, Robert F. Lemanske
The Journal of Allergy and Clinical Immunology In Practice (2014) Vol. 2, Iss. 6, pp. 658-663
Open Access | Times Cited: 80
Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan
Mitsuru Adachi, Masanari Kozawa, Hajime Yoshisue, et al.
Respiratory Medicine (2018) Vol. 141, pp. 56-63
Open Access | Times Cited: 76
Mitsuru Adachi, Masanari Kozawa, Hajime Yoshisue, et al.
Respiratory Medicine (2018) Vol. 141, pp. 56-63
Open Access | Times Cited: 76
Biologics in Asthma—The Next Step Toward Personalized Treatment
Jared I. Darveaux, William W. Busse
The Journal of Allergy and Clinical Immunology In Practice (2015) Vol. 3, Iss. 2, pp. 152-160
Open Access | Times Cited: 75
Jared I. Darveaux, William W. Busse
The Journal of Allergy and Clinical Immunology In Practice (2015) Vol. 3, Iss. 2, pp. 152-160
Open Access | Times Cited: 75
Longterm clinical outcomes of omalizumab therapy in severe allergic asthma: Study of efficacy and safety
Adel Mansur, Sapna Srivastava, V Mitchell, et al.
Respiratory Medicine (2017) Vol. 124, pp. 36-43
Open Access | Times Cited: 72
Adel Mansur, Sapna Srivastava, V Mitchell, et al.
Respiratory Medicine (2017) Vol. 124, pp. 36-43
Open Access | Times Cited: 72
Gender Differences in IgE-Mediated Allergic Asthma in the Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) Study
June H. Lee, Tmirah Haselkorn, Bradley E. Chipps, et al.
Journal of Asthma (2006) Vol. 43, Iss. 3, pp. 179-184
Closed Access | Times Cited: 89
June H. Lee, Tmirah Haselkorn, Bradley E. Chipps, et al.
Journal of Asthma (2006) Vol. 43, Iss. 3, pp. 179-184
Closed Access | Times Cited: 89
Aeroallergen sensitization correlates with PC20 and exhaled nitric oxide in subjects with mild-to-moderate asthma
Timothy Craig, Tonya S. King, Robert F. Lemanske, et al.
Journal of Allergy and Clinical Immunology (2008) Vol. 121, Iss. 3, pp. 671-677
Closed Access | Times Cited: 87
Timothy Craig, Tonya S. King, Robert F. Lemanske, et al.
Journal of Allergy and Clinical Immunology (2008) Vol. 121, Iss. 3, pp. 671-677
Closed Access | Times Cited: 87
Update on optimal use of omalizumab in management of asthma
Girolamo Pelaia
Journal of Asthma and Allergy (2011), pp. 49-49
Open Access | Times Cited: 65
Girolamo Pelaia
Journal of Asthma and Allergy (2011), pp. 49-49
Open Access | Times Cited: 65
Racial disparities in asthma-related health outcomes in severe or difficult-to-treat asthma
Tmirah Haselkorn, June H. Lee, David R. Mink, et al.
Annals of Allergy Asthma & Immunology (2008) Vol. 101, Iss. 3, pp. 256-263
Closed Access | Times Cited: 71
Tmirah Haselkorn, June H. Lee, David R. Mink, et al.
Annals of Allergy Asthma & Immunology (2008) Vol. 101, Iss. 3, pp. 256-263
Closed Access | Times Cited: 71
Relationship between pretreatment specific IgE and the response to omalizumab therapy
Ulrich Wahn, Cristina Martín, P. R. Freeman, et al.
Allergy (2009) Vol. 64, Iss. 12, pp. 1780-1787
Closed Access | Times Cited: 67
Ulrich Wahn, Cristina Martín, P. R. Freeman, et al.
Allergy (2009) Vol. 64, Iss. 12, pp. 1780-1787
Closed Access | Times Cited: 67
Targeted GATA3 knockdown in activated T cells via pulmonary siRNA delivery as novel therapy for allergic asthma
Rima Kandil, Domizia Baldassi, Sebastian Böhlen, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 305-315
Open Access | Times Cited: 11
Rima Kandil, Domizia Baldassi, Sebastian Böhlen, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 305-315
Open Access | Times Cited: 11
Omalizumab Protects against Allergen- Induced Bronchoconstriction in Allergic (Immunoglobulin E-Mediated) Asthma
Stefan Zielen, A. Lieb, Stephan De La Motte, et al.
International Archives of Allergy and Immunology (2012) Vol. 160, Iss. 1, pp. 102-110
Closed Access | Times Cited: 43
Stefan Zielen, A. Lieb, Stephan De La Motte, et al.
International Archives of Allergy and Immunology (2012) Vol. 160, Iss. 1, pp. 102-110
Closed Access | Times Cited: 43
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study
Corrado Pelaia, Cecilia Calabrese, Sarah Barbuto, et al.
Pulmonary Pharmacology & Therapeutics (2018) Vol. 54, pp. 25-30
Closed Access | Times Cited: 36
Corrado Pelaia, Cecilia Calabrese, Sarah Barbuto, et al.
Pulmonary Pharmacology & Therapeutics (2018) Vol. 54, pp. 25-30
Closed Access | Times Cited: 36
Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma
Girolamo Pelaia, Luca Gallelli, Pasquale Romeo, et al.
International Journal of Clinical Pharmacology and Therapeutics (2011) Vol. 49, Iss. 12, pp. 713-721
Closed Access | Times Cited: 35
Girolamo Pelaia, Luca Gallelli, Pasquale Romeo, et al.
International Journal of Clinical Pharmacology and Therapeutics (2011) Vol. 49, Iss. 12, pp. 713-721
Closed Access | Times Cited: 35
Omalizumab in patients with allergic (IgE-mediated) asthma and IgE/bodyweight combinations above those in the initially approved dosing table
Oliver Kornmann, Henrik Watz, Rainard Fuhr, et al.
Pulmonary Pharmacology & Therapeutics (2014) Vol. 28, Iss. 2, pp. 149-153
Open Access | Times Cited: 33
Oliver Kornmann, Henrik Watz, Rainard Fuhr, et al.
Pulmonary Pharmacology & Therapeutics (2014) Vol. 28, Iss. 2, pp. 149-153
Open Access | Times Cited: 33
Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study
Giorgio Walter Canonica, Paola Rottoli, Caterina Bucca, et al.
World Allergy Organization Journal (2018) Vol. 11, pp. 33-33
Open Access | Times Cited: 29
Giorgio Walter Canonica, Paola Rottoli, Caterina Bucca, et al.
World Allergy Organization Journal (2018) Vol. 11, pp. 33-33
Open Access | Times Cited: 29
The use of omalizumab in asthma
David Price
Primary Care Respiratory Journal (2008) Vol. 17, Iss. 2, pp. 62-72
Open Access | Times Cited: 38
David Price
Primary Care Respiratory Journal (2008) Vol. 17, Iss. 2, pp. 62-72
Open Access | Times Cited: 38
Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study
Andriana Ι. Papaioannou, Myrto Mplizou, Κonstantinos Porpodis, et al.
Allergy and Asthma Proceedings (2021) Vol. 42, Iss. 3, pp. 235-242
Closed Access | Times Cited: 19
Andriana Ι. Papaioannou, Myrto Mplizou, Κonstantinos Porpodis, et al.
Allergy and Asthma Proceedings (2021) Vol. 42, Iss. 3, pp. 235-242
Closed Access | Times Cited: 19
Immunologic Pathophysiology and Airway Remodeling Mechanism in Severe Asthma: Focused on IgE-Mediated Pathways
Shih-Lung Cheng
Diagnostics (2021) Vol. 11, Iss. 1, pp. 83-83
Open Access | Times Cited: 14
Shih-Lung Cheng
Diagnostics (2021) Vol. 11, Iss. 1, pp. 83-83
Open Access | Times Cited: 14
Recent 5-year trends of asthma severity and allergen sensitization among children in southern Thailand
Araya Yuenyongviwat
Asian Pacific Journal of Allergy and Immunology (2013) Vol. 31, Iss. -
Closed Access | Times Cited: 17
Araya Yuenyongviwat
Asian Pacific Journal of Allergy and Immunology (2013) Vol. 31, Iss. -
Closed Access | Times Cited: 17
Review: Omalizumab in the treatment of severe asthma: efficacy and current problems
Girolamo Pelaia, Teresa Renda, Pasquale Romeo, et al.
Therapeutic Advances in Respiratory Disease (2008) Vol. 2, Iss. 6, pp. 409-421
Open Access | Times Cited: 20
Girolamo Pelaia, Teresa Renda, Pasquale Romeo, et al.
Therapeutic Advances in Respiratory Disease (2008) Vol. 2, Iss. 6, pp. 409-421
Open Access | Times Cited: 20
New insights into the treatment of severe asthma in children
Lisa Giovannini‐Chami, Marc Albertini, P. Scheinmann, et al.
Paediatric Respiratory Reviews (2014) Vol. 16, Iss. 3, pp. 167-173
Closed Access | Times Cited: 14
Lisa Giovannini‐Chami, Marc Albertini, P. Scheinmann, et al.
Paediatric Respiratory Reviews (2014) Vol. 16, Iss. 3, pp. 167-173
Closed Access | Times Cited: 14
